4-Chloro-6-Iodo-Quinazoline Specs | Industrial Purity & Bulk Supply
The global pharmaceutical landscape demands rigorous consistency for critical oncology intermediates. As supply chains tighten, securing a reliable source for halogenated quinazoline compounds becomes a strategic priority for executive leadership. NINGBO INNO PHARMCHEM CO.,LTD. delivers stable manufacturing capacity, ensuring that procurement teams avoid costly delays associated with volatile market conditions. For detailed market analysis, review our report on 4-Chloro-6-Iodoquinazoline Bulk Price Global Manufacturer 2026 to understand current pricing trends.
Technical specifications and analytical methods
This quinazoline derivative serves as a vital kinase inhibitor precursor requiring precise characterization. Our industrial batches undergo strict GC and HPLC testing to verify composition against standard references.
| Parameter | Specification |
|---|---|
| CAS Number | 98556-31-1 |
| Chemical Name | 4-Chloro-6-iodoquinazoline |
| Molecular Formula | C8H4ClIN2 |
| Molecular Weight | 290.49 g/mol |
| Purity | >98.0% (GC) |
| Appearance | Light Brown to Dark Grey Solid |
| Melting Point | 175.0 to 179.0 °C |
| Storage | Under inert gas at 2–8 °C |
Troubleshooting common impurities and yield issues
Scaling production often introduces variability. Understanding the Lapatinib Intermediate Synthesis Route 6-Iodo-4-Chloroquinazoline helps identify potential bottlenecks in chlorination and iodination steps.
Managing Dehalogenation Byproducts
Trace deiodinated species can affect downstream coupling reactions. We utilize specialized purification protocols to maintain industrial purity levels above 98%.
Optimizing Chlorination Efficiency
Incomplete conversion of the quinazolinone precursor leads to yield loss. Our process controls ensure complete reaction while minimizing side products.
Strict Quality Assurance (QA) workflow and COA verification process
Every batch is accompanied by a verifiable COA detailing impurity profiles and physical constants. At NINGBO INNO PHARMCHEM CO.,LTD., we prioritize transparency to support your regulatory filings. For projects requiring specific modifications, our custom synthesis team adapts protocols to meet unique R&D requirements without sacrificing compliance.
Partnering with an experienced manufacturer mitigates risk and ensures continuity for your drug development pipeline.
Ready to optimize your supply chain? Reach out to our logistics team today for comprehensive specifications and tonnage availability.